| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 46.4377 | 34 |
| GSM780708 | Untreated after 4 days (C2_1) | 53.0989 | 56 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.9558 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 59.8507 | 64 |
| GSM780720 | Untreated after 4 days (C2_2) | 51.8206 | 54 |
| GSM780721 | Untreated after 4 days (C3_2) | 59.7947 | 64 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 51.0108 | 51 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 58.9393 | 64 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 50.4121 | 50 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.2498 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 60.8161 | 65 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 53.3645 | 57 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 60.1815 | 65 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 56.9401 | 62 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 55.3429 | 60 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 55.8735 | 61 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.2098 | 49 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.9653 | 48 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.2723 | 23 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 54.1655 | 58 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 54.3587 | 59 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.7069 | 60 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 54.825 | 59 |